Connect Biopharmaceuticals is based in Suzhou, China. It has raised $195M in total funding. Latest round: Series C.
Connect Biopharmaceuticals is based in Suzhou, China. Connect Biopharmaceuticals has raised $195M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in August 2020. The round record for Connect Biopharmaceuticals runs through 2020; nothing later has been disclosed. Investors on record include RA Capital Management, Boxer Capital, HBM Healthcare Investment, Lilly Asia Ventures, Qiming Venture Partners. 5 distinct backers are named across the disclosed rounds.
Every Connect Biopharmaceuticals figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Suzhou at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026